Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
30.15
0.00 (0.00%)
Sep 15, 2025, 4:00 PM EDT - Market open
HRTS Holdings Information
HRTS is an equity ETF with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 7.94%, UnitedHealth Group at 5.05%, Abbott Laboratories at 4.49%, AstraZeneca at 4.37%, and Roche Holding AG at 4.27%.
Total Holdings
46
Top 10 Percentage
43.21%
Asset Class
Equity
ETF Category
Health
Assets
50.50M
PE Ratio
20.30
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 7.94% |
| 2 | UNH | UnitedHealth Group Incorporated | 5.05% |
| 3 | ABT | Abbott Laboratories | 4.49% |
| 4 | LON: AZN | AstraZeneca PLC | 4.37% |
| 5 | RHHBY | Roche Holding AG | 4.27% |
| 6 | BSX | Boston Scientific Corporation | 3.79% |
| 7 | ABBV | AbbVie Inc. | 3.41% |
| 8 | TMO | Thermo Fisher Scientific Inc. | 3.38% |
| 9 | GILD | Gilead Sciences, Inc. | 3.31% |
| 10 | SWX: NOVN | Novartis AG | 3.20% |
| 11 | CPH: NOVO.B | Novo Nordisk A/S | 3.17% |
| 12 | BBIO | BridgeBio Pharma, Inc. | 3.08% |
| 13 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.00% |
| 14 | MDT | Medtronic plc | 2.96% |
| 15 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.50% |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 2.49% |
| 17 | MRK | Merck & Co., Inc. | 2.42% |
| 18 | DHR | Danaher Corporation | 2.34% |
| 19 | AMGN | Amgen Inc. | 2.29% |
| 20 | CYTK | Cytokinetics, Incorporated | 2.26% |
| 21 | EW | Edwards Lifesciences Corporation | 2.04% |
| 22 | REGN | Regeneron Pharmaceuticals, Inc. | 1.97% |
| 23 | BMY | Bristol-Myers Squibb Company | 1.92% |
| 24 | DXCM | DexCom, Inc. | 1.81% |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.79% |
As of Sep 9, 2025